These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 18774175

  • 1. Comparing metabolic effects of six different commercial trivalent chromium compounds.
    Preuss HG, Echard B, Perricone NV, Bagchi D, Yasmin T, Stohs SJ.
    J Inorg Biochem; 2008 Nov; 102(11):1986-90. PubMed ID: 18774175
    [Abstract] [Full Text] [Related]

  • 2. Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats.
    Preuss HG, Grojec PL, Lieberman S, Anderson RA.
    Clin Nephrol; 1997 May; 47(5):325-30. PubMed ID: 9181280
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety evaluation of a novel oxygen-coordinated niacin-bound chromium (III) complex.
    Shara M, Kincaid AE, Limpach AL, Sandstrom R, Barrett L, Norton N, Bramble JD, Yasmin T, Tran J, Chatterjee A, Bagchi M, Bagchi D.
    J Inorg Biochem; 2007 Jul; 101(7):1059-69. PubMed ID: 17555823
    [Abstract] [Full Text] [Related]

  • 4. Safety and toxicological evaluation of a novel niacin-bound chromium (III) complex.
    Shara M, Yasmin T, Kincaid AE, Limpach AL, Bartz J, Brenneman KA, Chatterjee A, Bagchi M, Stohs SJ, Bagchi D.
    J Inorg Biochem; 2005 Nov; 99(11):2161-83. PubMed ID: 16169591
    [Abstract] [Full Text] [Related]

  • 5. Effects of chromium and guar on sugar-induced hypertension in rats.
    Preuss HG, Gondal JA, Bustos E, Bushehri N, Lieberman S, Bryden NA, Polansky MM, Anderson RA.
    Clin Nephrol; 1995 Sep; 44(3):170-7. PubMed ID: 8556833
    [Abstract] [Full Text] [Related]

  • 6. Blood pressure lowering effects of niacin-bound chromium(III) (NBC) in sucrose-fed rats: renin-angiotensin system.
    Perricone NV, Bagchi D, Echard B, Preuss HG.
    J Inorg Biochem; 2008 Jul; 102(7):1541-8. PubMed ID: 18374418
    [Abstract] [Full Text] [Related]

  • 7. Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats.
    Talpur N, Echard BW, Yasmin T, Bagchi D, Preuss HG.
    Mol Cell Biochem; 2003 Oct; 252(1-2):369-77. PubMed ID: 14577612
    [Abstract] [Full Text] [Related]

  • 8. Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate.
    Bagchi D, Bagchi M, Balmoori J, Ye X, Stohs SJ.
    Res Commun Mol Pathol Pharmacol; 1997 Sep; 97(3):335-46. PubMed ID: 9387193
    [Abstract] [Full Text] [Related]

  • 9. Chromium picolinate for insulin resistance in subjects with HIV disease: a pilot study.
    Feiner JJ, McNurlan MA, Ferris RE, Mynarcik DC, Gelato MC.
    Diabetes Obes Metab; 2008 Feb; 10(2):151-8. PubMed ID: 18190429
    [Abstract] [Full Text] [Related]

  • 10. Comparing effects of carbohydrate (CHO) blockers and trivalent chromium on CHO-induced insulin resistance and elevated blood pressure in rats.
    Preuss HG, Echard B, Bagchi D, Perricone NV.
    J Am Coll Nutr; 2013 Feb; 32(1):58-65. PubMed ID: 24015700
    [Abstract] [Full Text] [Related]

  • 11. Long-term metabolic effects of different doses of niacin-bound chromium on Sprague-Dawley rats.
    Perricone NV, Bagchi D, Echard B, Preuss HG.
    Mol Cell Biochem; 2010 May; 338(1-2):91-103. PubMed ID: 20012467
    [Abstract] [Full Text] [Related]

  • 12. Effects of Maitake mushroom fractions on blood pressure of Zucker fatty rats.
    Talpur N, Echard B, Dadgar A, Aggarwal S, Zhuang C, Bagchi D, Preuss HG.
    Res Commun Mol Pathol Pharmacol; 2002 May; 112(1-4):68-82. PubMed ID: 15080498
    [Abstract] [Full Text] [Related]

  • 13. [Chromium as an essential element].
    Racek J.
    Cas Lek Cesk; 2003 May; 142(6):335-9. PubMed ID: 12924032
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of chromium, grape seed extract, and zinc on various metabolic parameters of rats.
    Preuss HG, Montamarry S, Echard B, Scheckenbach R, Bagchi D.
    Mol Cell Biochem; 2001 Jul; 223(1-2):95-102. PubMed ID: 11681727
    [Abstract] [Full Text] [Related]

  • 15. The safety and efficacy of high-dose chromium.
    Lamson DW, Plaza SM.
    Altern Med Rev; 2002 Jun; 7(3):218-35. PubMed ID: 12126463
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of chromium, vanadium and gymnema sylvestre on sugar-induced blood pressure elevations in SHR.
    Preuss HG, Jarrell ST, Scheckenbach R, Lieberman S, Anderson RA.
    J Am Coll Nutr; 1998 Apr; 17(2):116-23. PubMed ID: 9550454
    [Abstract] [Full Text] [Related]

  • 17. Safety of trivalent chromium complexes: no evidence for DNA damage in human HaCaT keratinocytes.
    Hininger I, Benaraba R, Osman M, Faure H, Marie Roussel A, Anderson RA.
    Free Radic Biol Med; 2007 Jun 15; 42(12):1759-65. PubMed ID: 17512455
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxicity and oxidative mechanisms of different forms of chromium.
    Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG.
    Toxicology; 2002 Oct 30; 180(1):5-22. PubMed ID: 12324196
    [Abstract] [Full Text] [Related]

  • 19. Chromium picolinate may favorably influence the vascular risk associated with smoking by combating cortisol-induced insulin resistance.
    McCarty MF.
    Med Hypotheses; 2005 Oct 30; 64(6):1220-4. PubMed ID: 15823722
    [Abstract] [Full Text] [Related]

  • 20. Chromium picolinate increases membrane fluidity and rate of insulin internalization.
    Evans GW, Bowman TD.
    J Inorg Biochem; 1992 Jun 30; 46(4):243-50. PubMed ID: 1402875
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.